INVO Bioscience, Inc. (INVO) Financials

$0.00

$0 (0%)
Last update: 07:00 PM EST
Day's range
$0
Day's range
$0

INVO Income statement / Annual

Last year (2025), 's total revenue was $6.84 B, an increase of 104,634.38% from the previous year. In 2025, 's net income was -$25.13 M. See ,s key income statements, including revenue, expenses, profit, and income.

Period FY-2025 FY-2024 FY-2023 FY-2022 FY-2021 FY-2020 FY-2019 FY-2018 FY-2017 FY-2016
Period Ended 12/31/2025 12/31/2024 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019 12/31/2018 12/31/2017 12/31/2016
Operating Revenue $6.84 B $6.53 M $3.02 M $822.20 K $4.16 M $1.04 M $1.48 M $494.38 K $282.15 K $50.90 K
Cost of Revenue $4.28 B $3.66 M $1.93 M $331.52 K $145.05 K $88.76 K $139.67 K $90.37 K $51.95 K $15.09 K
Gross Profit $2.56 B $2.87 M $1.09 M $490.67 K $4.02 M $948.53 K $1.34 M $404.01 K $230.19 K $35.81 K
Gross Profit Ratio 0.37 0.44 0.36 0.6 0.97 0.91 0.91 0.82 0.82 0.7
Research and Development Expenses $0.00 $489.66 K $165.95 K $544.04 K $216.43 K $398.43 K $0.00 $0.00 $0.00 $0.00
General & Administrative Expenses $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Selling & Marketing Expenses $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Selling, General & Administrative Expenses $7.69 M $9.08 M $7.49 M $10.57 M $9.02 M $6.07 M $3.13 M $3.04 M $870.61 K $2.15 M
Other Expenses $9.79 B $1.43 M $200.89 K $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Operating Expenses $9.80 B $11.00 M $7.85 M $11.12 M $9.23 M $6.46 M $3.13 M $3.04 M $870.61 K $2.15 M
Cost And Expenses $14.08 B $14.66 M $9.79 M $11.45 M $9.38 M $6.55 M $3.27 M $3.13 M $922.57 K $2.16 M
Interest Income $0.00 $0.00 $0.00 $308.00 $3.66 K $4.19 K $8.63 K $0.00 $0.00 $0.00
Interest Expense -$1.30 M -$1.06 M $925.91 K $59.45 K $1.27 M $2.84 M $387.65 K $442.03 K $20.87 K $13.84 K
Depreciation & Amortization $677.36 K $919.60 K $200.89 K $306.32 K $166.08 K $34.48 K $25.35 K $5.19 K $2.81 K $1.88 K
EBITDA -$25.91 M -$9.51 M -$6.88 M -$10.52 M -$5.22 M -$5.48 M -$1.76 M -$2.63 M -$678.48 K -$2.11 M
EBITDA Ratio -0 -1.46 -2.28 -12.8 -1.25 -5.28 -1.19 -5.32 -2.4 -41.42
Operating Income Ratio -1.06 -1.24 -2.24 -12.92 -1.25 -5.32 -1.21 -5.33 -2.27 -41.46
Total Other Income/Expenses Net $1.75 B -$993.26 K -$1.24 M -$263.16 K -$1.43 M -$2.83 M -$379.02 K -$442.03 K -$61.74 K -$13.84 K
Income Before Tax -$5.49 B -$9.12 M -$8.01 M -$10.89 M -$6.65 M -$8.35 M -$2.17 M -$3.08 M -$702.16 K -$2.12 M
Income Before Tax Ratio -0.8 -1.4 -2.65 -13.24 -1.6 -8.05 -1.46 -6.22 -2.49 -41.73
Income Tax Expense -$150.37 M -$22.91 K $27.79 K $2.87 K $4.76 K $0.00 $433.00 $0.00 $0.00 $0.00
Net Income -$25.13 M -$9.35 M -$8.03 M -$10.89 M -$6.65 M -$8.35 M -$2.17 M -$3.08 M -$702.16 K -$2.12 M
Net Income Ratio -0 -1.43 -2.66 -13.25 -1.6 -8.05 -1.46 -6.22 -2.49 -41.73
EPS -214.64 -3019.48 -5.13 -17.97 -12.52 -30.41 -8.93 -12.76 -3.16 -9.67
EPS Diluted -214.64 -3019.48 -5.13 -17.97 -12.52 -30.41 -8.93 -12.76 -3.16 -9.67
Weighted Average Shares Out $117.08 M $3.10 M $1.57 M $606.13 K $531.62 K $274.49 K $242.74 K $241.08 K $222.08 K $219.68 K
Weighted Average Shares Out Diluted $117.08 M $3.10 M $1.57 M $606.13 K $531.62 K $274.49 K $242.74 K $241.08 K $222.08 K $219.68 K
Link